Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Precision Biosciences (DTIL) Other Gross PP&E Adjustments (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with $24.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 0.98% to $24.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.3 million through Dec 2025, up 0.98% year-over-year, with the annual reading at $24.3 million for FY2025, 0.98% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $24.3 million at Precision Biosciences, up from -$6.1 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $44.9 million in Q4 2021, with the low at -$8.0 million in Q1 2024.
  • Average Other Gross PP&E Adjustments over 5 years is $3.5 million, with a median of -$4.3 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments skyrocketed 67.28% in 2023, then plummeted 587.08% in 2024.
  • Over 5 years, Other Gross PP&E Adjustments stood at $44.9 million in 2021, then fell by 29.34% to $31.7 million in 2022, then decreased by 25.72% to $23.6 million in 2023, then increased by 2.17% to $24.1 million in 2024, then increased by 0.98% to $24.3 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $24.3 million, -$6.1 million, and -$6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.